查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949663

2026年全球基因編輯轉染化學品市場報告

Gene-Editing Transfection Chemicals Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基因編輯轉染試劑的市場規模顯著成長，預計將從2025年的10.7億美元成長到2026年的11.6億美元，複合年成長率（CAGR）為8.4%。過去幾年的成長可歸因於高效轉染試劑的供不應求、對傳統遞送方法的依賴、學術和研究活動的擴展、生物技術研究投資的增加以及基因編輯工具的早期應用。

預計未來幾年基因編輯轉染化學品市場將維持強勁成長，2030年市場規模將達到15.6億美元，複合年成長率（CAGR）為7.7%。預測期內的成長要素包括：先進的脂質、聚合物和肽基化學品的開發；對精準基因編輯應用的需求不斷成長；製藥和生物技術領域研發投入的擴大；自動化轉染平台的普及；監管核准的增加；以及標準化通訊協定的廣泛應用。預測期內的主要趨勢包括：脂質基轉染化學品的應用日益廣泛；聚合物和肽基遞送系統的使用日益增多；非病毒和病毒遞送機制的發展；基因編輯在藥物研發和疾病建模中的應用不斷擴展；以及對提高轉染效率和細胞活力的重視。

基因治療研究的快速進展預計將在未來幾年推動基因編輯轉染化學品市場的成長。基因治療是一種旨在透過直接修飾或修復患者細胞中的缺陷基因來治療或預防疾病的治療方法。 CRISPR等基因編輯技術的重大突破使得精準標靶化和修飾導致遺傳疾病的缺陷基因成為可能，加速了基因治療領域的研究活動。基因編輯轉染化學物質在基因治療的研發中發揮著至關重要的作用，因為它們能夠將CRISPR-Cas9組分、mRNA和質體DNA等遺傳物質高效導入人體細胞。例如，根據美國基因與細胞治療學會（ASGCT，一家總部位於美國的非營利醫療和科學組織）稱，截至2024年12月，食品藥物管理局（FDA）在2023年核准了6種基因治療產品，高於2022年的5種。因此，基因治療研究的加速發展正在推動基因編輯轉染化學品市場的成長。

基因編輯轉染化學品市場的主要企業正致力於推出創新解決方案，以簡化基因治療和mRNA遞送流程。例如，脂質奈米顆粒（LNP）入門試劑盒是即用型配方或工具包，包含預先最佳化的脂質成分和標準化通訊協定，旨在支援基於LNP的遞送系統的開發和測試。例如，總部位於瑞士的製藥公司CordenPharma於2024年2月推出了一款脂質奈米顆粒（LNP）入門試劑盒，用於支持mRNA療法（包括疫苗和基因療法）的製備和最佳化。這些試劑盒包含四種必需脂質——可電離脂質、輔助脂質、甾醇和聚乙二醇化脂質——並採用商業規模的高純度原料生產，以確保批次間的一致性，並將開發過程中高價值有效載荷的損失風險降至最低。透過提供可靠且擴充性的脂質平台，CordenPharma旨在加速基因編輯和mRNA療法的開發，同時保護寶貴的遺傳有效載荷。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球基因編輯轉染化學品市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 脂質體轉染化學方法的應用日益廣泛
    • 聚合物和肽基遞送系統的應用日益廣泛
    • 非病毒和病毒遞送機制的發展
    • 拓展基因編輯技術在藥物發現與疾病建模的應用
    • 重點在於提高轉染效率和細胞活力

第5章 終端用戶產業市場分析

  • 學術研究機構
  • 生技公司
  • 製藥公司
  • 合約研究組織（CRO）
  • 農業生物技術公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球基因編輯轉染化學品市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球基因編輯轉染化學品市場規模、比較及成長率分析
  • 全球基因編輯轉染化學品市場表現：規模與成長，2020-2025年
  • 全球基因編輯轉染化學品市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依化學類型
  • 基於脂質、聚合物、胜肽和其他化學類型的
  • 透過遞送機制
  • 非病毒性、病毒性
  • 透過使用
  • 生物醫學研究、藥物發現、疾病建模、農業生物技術、疫苗開發及其他應用
  • 最終用戶
  • 學術研究機構、生物技術和製藥公司以及其他最終用戶
  • 按類型細分：脂質類
  • 陽離子脂質、中性脂質、可電離脂質
  • 按類型細分：聚合物
  • 聚乙烯亞胺（PEI）、聚（L-離胺酸）（PLL）、樹狀聚合物
  • 按類型細分：胜肽
  • 細胞滲透性肽（CPP）、雙親性肽、標靶化肽
  • 依類型細分：其他化學品類型
  • 無機奈米粒子，混合奈米粒子

第10章 區域與國家分析

  • 全球基因編輯轉染化學品市場：按地區分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球基因編輯轉染化學品市場：依國家分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 基因編輯轉染化學品市場：競爭格局與市場佔有率，2024 年
  • 基因編輯轉染化學品市場：公司估值矩陣
  • 基因編輯轉染化學品市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Lonza Group AG
    • Takara Bio Inc.
    • Mirus Bio LLC

第37章：其他領先和創新企業

  • OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, SignaGen Laboratories

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年基因編輯轉染化學品市場：提供新機會的國家
  • 2030年基因編輯轉染化學品市場：提供新機會的細分市場
  • 2030年基因編輯轉染化學品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH4MGTCR01_G26Q1

Gene-editing transfection chemicals are specialized agents designed to facilitate the effective delivery of gene-editing tools such as CRISPR-Cas9 complexes, plasmid DNA, or RNA molecules into living cells by assisting their passage across the cell membrane while preventing degradation. These chemicals play a crucial role in achieving high transfection efficiency and successful genome modification, as they safeguard the genetic material and support its cellular uptake, expression, and functional activity within target cells.

The key categories of gene-editing transfection chemicals include lipid-based, polymer-based, peptide-based, and others. Lipid-based gene-editing transfection chemicals are delivery agents made of lipid molecules that aid in transporting gene-editing tools, including CRISPR-Cas9, into target cells. These chemicals employ various delivery approaches, such as non-viral and viral methods, and are used across a broad range of applications, including biomedical research, drug discovery, disease modeling, agricultural biotechnology, vaccine development, and others. The major end users include academic and research institutions, biotechnology companies, pharmaceutical companies, and others.

Tariffs have affected the gene-editing transfection chemicals market by increasing the cost of imported high-purity reagents, specialized lipids, and polymer-based chemicals. Segments such as lipid-based and peptide-based transfection chemicals are particularly impacted, with regions like North America, Europe, and Asia-Pacific facing supply chain cost pressures. While tariffs have led to increased production costs and slowed adoption in some regions, they also encourage local production, development of alternative formulations, and investment in domestic manufacturing capabilities.

The gene-editing transfection chemicals market research report is one of a series of new reports from The Business Research Company that provides gene-editing transfection chemicals market statistics, including gene-editing transfection chemicals industry global market size, regional shares, competitors with a gene-editing transfection chemicals market share, detailed gene-editing transfection chemicals market segments, market trends and opportunities, and any further data you may need to thrive in the gene-editing transfection chemicals industry. This gene-editing transfection chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene-editing transfection chemicals market size has grown strongly in recent years. It will grow from $1.07 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of high-efficiency transfection chemicals, reliance on traditional delivery methods, growing academic and research institute activities, increasing investment in biotechnology research, early adoption of gene-editing tools.

The gene-editing transfection chemicals market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of advanced lipid, polymer, and peptide-based chemicals, rising demand for precise gene-editing applications, expansion in pharmaceutical and biotechnology R&D, integration of automated transfection platforms, increasing regulatory approvals and standardized protocols. Major trends in the forecast period include rising adoption of lipid-based transfection chemicals, increased use of polymer and peptide-based delivery systems, growth in non-viral and viral delivery mechanisms, expansion of gene-editing applications in drug discovery and disease modeling, focus on improving transfection efficiency and cell viability.

The rapid advancement of research in gene therapy is anticipated to drive the growth of the gene-editing transfection chemicals market in the coming years. Gene therapy is a therapeutic approach aimed at treating or preventing diseases by directly altering or repairing defective genes within a patient's cells. Research activity in gene therapy is accelerating due to major breakthroughs in gene-editing technologies such as CRISPR, which enable precise targeting and modification of faulty genes responsible for genetic disorders. Gene-editing transfection chemicals play a critical role in gene therapy research and development, as they facilitate the efficient delivery of genetic materials, including CRISPR-Cas9 components, mRNA, and plasmid DNA, into human cells. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, an increase from five approvals in 2022. Therefore, the acceleration of gene therapy research is contributing to the growth of the gene-editing transfection chemicals market.

Leading companies operating in the gene-editing transfection chemicals market are concentrating on the introduction of innovative solutions, such as lipid nanoparticle (LNP) starter kits, to simplify gene therapy and mRNA delivery workflows. Lipid nanoparticle (LNP) starter kits are ready-to-use formulations or toolsets that include pre-optimized lipid components and standardized protocols designed to support the development and testing of LNP-based delivery systems. For example, in February 2024, CordenPharma, a Switzerland-based pharmaceutical company, launched Lipid NanoParticle (LNP) Starter Kits to assist researchers and developers in formulating and optimizing mRNA-based therapeutics, including vaccines and gene therapies. These kits contain four essential lipid types, including ionizable lipids, helper lipids, sterols, and PEGylated lipids, derived from commercial-scale, high-purity materials to ensure batch-to-batch consistency and minimize the risk of losing high-value payloads during development. By offering a dependable and scalable lipid platform, CordenPharma seeks to accelerate gene editing and mRNA therapeutic development while protecting valuable genetic payloads.

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio LLC for $600 million. Through this acquisition, Merck aimed to further its objective of delivering fully integrated and end-to-end solutions across all stages of viral vector manufacturing, supporting the development and commercialization of cell and gene therapies from preclinical research to commercial production. Mirus Bio LLC is a US-based company that produces transfection reagents used in gene editing as well as other cell and gene therapy applications.

Major companies operating in the gene-editing transfection chemicals market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Takara Bio Inc., Mirus Bio LLC, OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, SignaGen Laboratories.

North America was the largest region in the gene-editing transfection chemicals market in 2025. The regions covered in the gene-editing transfection chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene-editing transfection chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene-editing transfection chemicals market consists of sales of products, including lipid-based transfection reagents, polymer-based transfection reagents, electroporation buffers and kits, nanoparticle-based delivery systems, and cell-specific transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene-Editing Transfection Chemicals Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gene-editing transfection chemicals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene-editing transfection chemicals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene-editing transfection chemicals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Chemical Type: Lipid-Based; Polymer-Based; Peptide-Based; Other Chemical Types
  • 2) By Delivery Mechanism: Non-Viral; Viral
  • 3) By Application: Biomedical Research; Drug Discovery; Disease Modeling; Agricultural Biotechnology; Vaccine Development; Other Applications
  • 4) By End-User: Academic And Research Institutes; Biotechnology Companies; Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Lipid-Based: Cationic Lipids; Neutral Lipids; Ionizable Lipids
  • 2) By Polymer-Based: Polyethyleneimine (PEI); Poly(L-Lysine) (PLL); Dendrimers
  • 3) By Peptide-Based: Cell-Penetrating Peptides (CPPs); Amphipathic Peptides; Targeting Peptides
  • 4) By Other Chemical Types: Inorganic Nanoparticles; Hybrid Nanoparticles
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG; Takara Bio Inc.; Mirus Bio LLC; OZ Biosciences SAS; Genlantis Inc.; Polyplus-Transfection SA; Altogen Biosystems LLC; SignaGen Laboratories.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Gene-Editing Transfection Chemicals Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Gene-Editing Transfection Chemicals Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Gene-Editing Transfection Chemicals Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Gene-Editing Transfection Chemicals Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Lipid-Based Transfection Chemicals
    • 4.2.2 Increased Use Of Polymer And Peptide-Based Delivery Systems
    • 4.2.3 Growth In Non-Viral And Viral Delivery Mechanisms
    • 4.2.4 Expansion Of Gene-Editing Applications In Drug Discovery And Disease Modeling
    • 4.2.5 Focus On Improving Transfection Efficiency And Cell Viability

5. Gene-Editing Transfection Chemicals Market Analysis Of End Use Industries

  • 5.1 Academic And Research Institutes
  • 5.2 Biotechnology Companies
  • 5.3 Pharmaceutical Companies
  • 5.4 Contract Research Organizations (Cros)
  • 5.5 Agricultural Biotechnology Companies

6. Gene-Editing Transfection Chemicals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gene-Editing Transfection Chemicals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Gene-Editing Transfection Chemicals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Gene-Editing Transfection Chemicals Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Gene-Editing Transfection Chemicals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Gene-Editing Transfection Chemicals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gene-Editing Transfection Chemicals Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gene-Editing Transfection Chemicals Market Segmentation

  • 9.1. Global Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lipid-Based, Polymer-Based, Peptide-Based, Other Chemical Types
  • 9.2. Global Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Viral, Viral
  • 9.3. Global Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biomedical Research, Drug Discovery, Disease Modeling, Agricultural Biotechnology, Vaccine Development, Other Applications
  • 9.4. Global Gene-Editing Transfection Chemicals Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Institutes, Biotechnology Companies, Pharmaceutical Companies, Other End-Users
  • 9.5. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Lipid-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cationic Lipids, Neutral Lipids, Ionizable Lipids
  • 9.6. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polyethyleneimine (PEI), Poly(L-Lysine) (PLL), Dendrimers
  • 9.7. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Peptide-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell-Penetrating Peptides (CPPs), Amphipathic Peptides, Targeting Peptides
  • 9.8. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Other Chemical Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Inorganic Nanoparticles, Hybrid Nanoparticles

10. Gene-Editing Transfection Chemicals Market Regional And Country Analysis

  • 10.1. Global Gene-Editing Transfection Chemicals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Gene-Editing Transfection Chemicals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gene-Editing Transfection Chemicals Market

  • 11.1. Asia-Pacific Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gene-Editing Transfection Chemicals Market

  • 12.1. China Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gene-Editing Transfection Chemicals Market

  • 13.1. India Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gene-Editing Transfection Chemicals Market

  • 14.1. Japan Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gene-Editing Transfection Chemicals Market

  • 15.1. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gene-Editing Transfection Chemicals Market

  • 16.1. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gene-Editing Transfection Chemicals Market

  • 17.1. South Korea Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gene-Editing Transfection Chemicals Market

  • 18.1. Taiwan Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gene-Editing Transfection Chemicals Market

  • 19.1. South East Asia Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gene-Editing Transfection Chemicals Market

  • 20.1. Western Europe Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gene-Editing Transfection Chemicals Market

  • 21.1. UK Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gene-Editing Transfection Chemicals Market

  • 22.1. Germany Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gene-Editing Transfection Chemicals Market

  • 23.1. France Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gene-Editing Transfection Chemicals Market

  • 24.1. Italy Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gene-Editing Transfection Chemicals Market

  • 25.1. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gene-Editing Transfection Chemicals Market

  • 26.1. Eastern Europe Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gene-Editing Transfection Chemicals Market

  • 27.1. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gene-Editing Transfection Chemicals Market

  • 28.1. North America Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gene-Editing Transfection Chemicals Market

  • 29.1. USA Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gene-Editing Transfection Chemicals Market

  • 30.1. Canada Gene-Editing Transfection Chemicals Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gene-Editing Transfection Chemicals Market

  • 31.1. South America Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gene-Editing Transfection Chemicals Market

  • 32.1. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gene-Editing Transfection Chemicals Market

  • 33.1. Middle East Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gene-Editing Transfection Chemicals Market

  • 34.1. Africa Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Segmentation By Delivery Mechanism, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gene-Editing Transfection Chemicals Market Regulatory and Investment Landscape

36. Gene-Editing Transfection Chemicals Market Competitive Landscape And Company Profiles

  • 36.1. Gene-Editing Transfection Chemicals Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Gene-Editing Transfection Chemicals Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Gene-Editing Transfection Chemicals Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Mirus Bio LLC Overview, Products and Services, Strategy and Financial Analysis

37. Gene-Editing Transfection Chemicals Market Other Major And Innovative Companies

  • OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, SignaGen Laboratories

38. Global Gene-Editing Transfection Chemicals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gene-Editing Transfection Chemicals Market

40. Gene-Editing Transfection Chemicals Market High Potential Countries, Segments and Strategies

  • 40.1 Gene-Editing Transfection Chemicals Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Gene-Editing Transfection Chemicals Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Gene-Editing Transfection Chemicals Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer